Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Abbott acquires exclusive marketing rights for Actos in Latin America from Takeda

March 9, 2000

Effects of NO-1886 on lipid levels and LPL activity in WHHL rabbits

March 8, 2000

Lead structure for the design of tissue-selective ER ligands discovered at Novo Nordisk

March 8, 2000

U.S. university researchers synthesize new series of PPARgamma agonists

March 8, 2000

Novo Nordisk and Schering-Plough conclude diabetes copromotion agreement

March 7, 2000

Ixion's transplanted islet cells for diabetes featured in Nature Medicine

March 6, 2000

Alendronate nitrate: a new bisphosphonate salt with reduced GI toxicity

March 6, 2000

FDA issues second approvable letter for mifepristone

March 6, 2000

Actonel to be approved in Europe for Rx of postmenopausal osteoporosis

March 3, 2000

New vitamin D4 metabolite claimed by Bone Care for vitamin D-deficient states

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...